BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.820
-0.180 (-4.50%)
At close: Feb 27, 2026, 4:00 PM EST
3.950
+0.130 (3.40%)
After-hours: Feb 27, 2026, 6:46 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $27.70 million as of February 27, 2026. Its market cap has increased by 149.56% in one year.
Market Cap
27.70M
Enterprise Value
16.60M
1-Year Change
149.56%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $27.70M, an increase of 6.54%. That is a compound annual growth rate of 1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 7.20M | -46.27% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 28.11M |
| IGC Pharma | 27.80M |
| Hyperion DeFi | 27.04M |
| Lixte Biotechnology Holdings | 26.49M |
| Boundless Bio | 26.19M |
| Marker Therapeutics | 25.84M |
| Cue Biopharma | 25.84M |
| Reviva Pharmaceuticals Holdings | 25.77M |